Australia, Dec. 11 -- Neuroscientific Biopharmaceutical (NSB) has reported gross short sales of 436 FPO shares on Dec. 9. The percent of issued capital of the company reported as short sales is 0.0 percent. The issued capital of the company is 144,604,870 shares.
Disclaimer: Curated by HT Syndication.
